Ariana P. Vargas-Delgado

Author

Also Known As

Ariana P. Vargas-Delgado, Ariana Patricia Vargas-Delgado, Ariana Vargas-Delgado

Publications

Citations

H-Index

Concepts

All Affiliations

Ariana P. Vargas-Delgado is an author at Icahn School of Medicine at Mount Sinai specializing in diabetes, cardiovascular disease, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	969
2	Diabetes	4	4	969
3	Health Sciences	2	2	427
4	Physiology	2	2	427
5	Pharmacology	1	1	244

Ariana P. Vargas-Delgado

Publications

969

Citations

H-Index

Page 1

	Year	Citations
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction Carlos G. Santos‐Gallego, Ariana P. Vargas-Delgado, Juan Antonio Requena-Ibáñez, Journal of the American College of Cardiology Diabetes ManagementHeart FailureCardiovascular DiseaseNondiabetic PatientsDiabetes	2020	492
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, Anderly Rodriguez-Cordero, JACC Heart Failure Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseMedicineInsulin Management	2021	244
Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio, JACC. Cardiovascular imaging Metabolic SyndromeLeft Ventricular Fibrosis/stiffnessHeart FailureCardiomyopathyCardiovascular Disease	2020	183
Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, Anderly Rodriguez-Cordero, Diabetes & Metabolic Syndrome Clinical Research & Reviews Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseInsulin ManagementDiabetes	2022	50

Page 1